Location · Fort Lauderdale, FL
Clinical trials in Fort Lauderdale, FL
59 recruiting studies have a site in Fort Lauderdale, and 18 of them accept healthy volunteers.
59 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
EyeBiotech Ltd.
- Location
- Fort Lauderdale, FL + 66 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2/Phase 3
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Janssen Research & Development, LLC
- Location
- Fort Lauderdale, FL + 44 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
- Location
- Fort Lauderdale, FL + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
ViiV Healthcare
- Location
- Fort Lauderdale, FL + 36 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
AstraZeneca
- Location
- Fort Lauderdale, FL + 104 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Fort Lauderdale, FL + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Adverum Biotechnologies, Inc.
- Location
- Fort Lauderdale, FL + 78 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Fort Lauderdale, FL + 35 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Nipro Vascular Innovations Americas, Inc
- Location
- Fort Lauderdale, FL + 16 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion
- Location
- Fort Lauderdale, FL + 31 other US sites
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
AstraZeneca
- Location
- Fort Lauderdale, FL + 206 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics
- Location
- Fort Lauderdale, FL + 19 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Gilead Sciences
- Location
- Fort Lauderdale, FL + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc.
- Location
- Fort Lauderdale, FL + 11 other US sites
- Eligibility basics
- Ages 50+
- Recruiting
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
FemPulse Corporation
- Location
- Fort Lauderdale, FL + 11 other US sites
- Eligibility basics
- Ages 21+ · Women only
- RecruitingPhase 3
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or…
Ocular Therapeutix, Inc.
- Location
- Fort Lauderdale, FL + 7 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc.
- Location
- Fort Lauderdale, FL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Fort Lauderdale, FL + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Ardelyx
- Location
- Fort Lauderdale, FL + 108 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Kodiak Sciences Inc
- Location
- Fort Lauderdale, FL + 47 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Kodiak Sciences Inc
- Location
- Fort Lauderdale, FL + 47 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
InSightec
- Location
- Fort Lauderdale, FL + 5 other US sites
- Eligibility basics
- Ages 50–85
- Recruiting
Freedom-1 Study for Chronic Knee Pain
Curonix LLC
- Location
- Fort Lauderdale, FL + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Wake Forest University Health Sciences
- Location
- Fort Lauderdale, FL + 101 other US sites
- Eligibility basics
- Ages 18+